Patient Testimonial

Fran's Story: Expanded Access Program Patient

Fran’s personal experience began in 1996, when her mother was diagnosed with acral lentiginous melanoma , which eventually took her life.  In 2017, Fran found a small red dot on her foot and immediately knew what it was – melanoma.

Fran received surgery, radiation, nivolumab, ipilimumab, pembrolizumab and T-VEC but the melanoma still spread throughout her body – including her lung, liver, chest cavity, neck and brain.

Fran then learned about TAVO™ (tavokinogene telseplasmid) from her oncologist and got access to treatment through the Expanded Access Program.

Watch Fran’s story to learn how she got off the one way street with a dead end.

OncoSec’s product candidates are investigational and have not been approved by the FDA. The results described in the testimonials may not be representative of the patient experience as the product candidates remain investigational.